These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20846941)

  • 21. A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease.
    Smedley D; Schubach M; Jacobsen JOB; Köhler S; Zemojtel T; Spielmann M; Jäger M; Hochheiser H; Washington NL; McMurry JA; Haendel MA; Mungall CJ; Lewis SE; Groza T; Valentini G; Robinson PN
    Am J Hum Genet; 2016 Sep; 99(3):595-606. PubMed ID: 27569544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease cases.
    Krämer A; Shah S; Rebres RA; Tang S; Richards DR
    BMC Genomics; 2017 Aug; 18(Suppl 5):551. PubMed ID: 28812537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the critical evaluation and confirmation of germline sequence variants identified using massively parallel sequencing.
    Kubiritova Z; Gyuraszova M; Nagyova E; Hyblova M; Harsanyova M; Budis J; Hekel R; Gazdarica J; Duris F; Kadasi L; Szemes T; Radvanszky J
    J Biotechnol; 2019 Jun; 298():64-75. PubMed ID: 30998956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GeneVetter: a web tool for quantitative monogenic assessment of rare diseases.
    Gillies CE; Robertson CC; Sampson MG; Kang HM
    Bioinformatics; 2015 Nov; 31(22):3682-4. PubMed ID: 26209433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
    Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
    BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of molecular genetic discoveries.
    Marian AJ
    Transl Res; 2016 Feb; 168():6-14. PubMed ID: 26548329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational methods for epigenetic analysis: the protocol of computational analysis for modified methylation-specific digital karyotyping based on massively parallel sequencing.
    Li J; Zhao Q; Bolund L
    Methods Mol Biol; 2011; 791():313-28. PubMed ID: 21913089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation sequencing technologies for rare Mendelian disorders: striking potential and ongoing challenges.
    Hoffjan S
    Mol Cell Probes; 2015 Oct; 29(5):259. PubMed ID: 26257290
    [No Abstract]   [Full Text] [Related]  

  • 29. TIA: algorithms for development of identity-linked SNP islands for analysis by massively parallel DNA sequencing.
    Farris MH; Scott AR; Texter PA; Bartlett M; Coleman P; Masters D
    BMC Bioinformatics; 2018 Apr; 19(1):126. PubMed ID: 29642839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underlying Data for Sequencing the Mitochondrial Genome with the Massively Parallel Sequencing Platform Ion Torrent™ PGM™.
    Seo SB; Zeng X; King JL; Larue BL; Assidi M; Al-Qahtani MH; Sajantila A; Budowle B
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S4. PubMed ID: 25924014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing challenges in the diagnosis and treatment of rare genetic diseases.
    Boycott KM; Ardigó D
    Nat Rev Drug Discov; 2018 Mar; 17(3):151-152. PubMed ID: 29242613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of SNP calling using single and multiple-sample calling algorithms by validation against array base genotyping and Mendelian inheritance.
    Kumar P; Al-Shafai M; Al Muftah WA; Chalhoub N; Elsaid MF; Aleem AA; Suhre K
    BMC Res Notes; 2014 Oct; 7():747. PubMed ID: 25339461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leveraging ancestry to improve causal variant identification in exome sequencing for monogenic disorders.
    Brown R; Lee H; Eskin A; Kichaev G; Lohmueller KE; Reversade B; Nelson SF; Pasaniuc B
    Eur J Hum Genet; 2016 Jan; 24(1):113-9. PubMed ID: 25898925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Disease Susceptibility Alleles in the Next Generation Sequencing Era.
    DiStefano JK; Kingsley CB
    Methods Mol Biol; 2018; 1706():3-16. PubMed ID: 29423790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linkage analysis and the study of Mendelian disease in the era of whole exome and genome sequencing.
    Teare MD; Santibañez Koref MF
    Brief Funct Genomics; 2014 Sep; 13(5):378-83. PubMed ID: 25024279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of massively parallel sequencing for posterior polymorphous corneal dystrophy type 3 molecular diagnosis.
    Dudakova L; Evans CJ; Pontikos N; Hafford-Tear NJ; Malinka F; Skalicka P; Horinek A; Munier FL; Voide N; Studeny P; Vanikova L; Kubena T; Rojas Lopez KE; Davidson AE; Hardcastle AJ; Tuft SJ; Liskova P
    Exp Eye Res; 2019 May; 182():160-166. PubMed ID: 30851240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Fast Association Test for Identifying Pathogenic Variants Involved in Rare Diseases.
    Greene D; ; Richardson S; Turro E
    Am J Hum Genet; 2017 Jul; 101(1):104-114. PubMed ID: 28669401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic footprinting.
    Vierstra J; Stamatoyannopoulos JA
    Nat Methods; 2016 Mar; 13(3):213-21. PubMed ID: 26914205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancements in Next-Generation Sequencing.
    Levy SE; Myers RM
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():95-115. PubMed ID: 27362342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans.
    Ewing AD; Kazazian HH
    Genome Res; 2011 Jun; 21(6):985-90. PubMed ID: 20980553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.